Cargando…

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors

BACKGROUND: An integrative analysis was conducted to identify genomic alterations at a pathway level that could predict overall survival (OS) in patients with advanced urothelial carcinoma (UC) treated with platinum-based chemotherapy. PATIENTS AND METHODS: DNA and RNA were extracted from 103 formal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellmunt, Joaquim, Werner, Lillian, Leow, Jeffrey J., Mullane, Stephanie A., Fay, André P., Riester, Markus, Van Hummelen, Paul, Taplin, Mary-Ellen, Choueiri, Toni K., Van Allen, Eliezer, Rosenberg, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454515/ https://www.ncbi.nlm.nih.gov/pubmed/26039708 http://dx.doi.org/10.1371/journal.pone.0124711

Ejemplares similares

Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma
por: Mullane, Stephanie A., et al.
Publicado: (2016)

Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
por: Bellmunt, Joaquim, et al.
Publicado: (2016)

HER2 as a target in invasive urothelial carcinoma
por: Bellmunt, Joaquim, et al.
Publicado: (2015)

The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine
por: Harshman, L C, et al.
Publicado: (2013)

DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors
por: Bambury, Richard M, et al.
Publicado: (2015)

Identification of ALK Gene Alterations in Urothelial Carcinoma
por: Bellmunt, Joaquim, et al.
Publicado: (2014)

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)
por: Rosenberg, Jonathan E., et al.
Publicado: (2018)

Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma
por: Bellmunt, Joaquim, et al.
Publicado: (2018)

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
por: Guancial, Elizabeth A, et al.
Publicado: (2014)

Upper tract urothelial carcinoma: a different disease entity in terms of management
por: Leow, Jeffrey J, et al.
Publicado: (2017)

Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma
por: Hoffman-Censits, Jean, et al.
Publicado: (2020)

Urothelial carcinoma management in elderly or unfit patients()
por: Bellmunt, Joaquim, et al.
Publicado: (2016)

Somatic ERCC2 Mutations Are Associated with a Distinct Genomic Signature in Urothelial Tumors
por: Kim, Jaegil, et al.
Publicado: (2016)

Concurrent palliative radiation with pembrolizumab for platinum-refractory urothelial carcinoma is associated with improved overall survival
por: Nakamori, Keita, et al.
Publicado: (2022)

A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma
por: Nassar, Amin H., et al.
Publicado: (2019)

Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
por: Grande, Enrique, et al.
Publicado: (2023)

Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder
por: Lee, Dong Hyeon, et al.
Publicado: (2018)

Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database
por: Fay, Andre P., et al.
Publicado: (2018)

Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer
por: Bowden, Michaela, et al.
Publicado: (2020)

Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials
por: Moreira, Raphael B., et al.
Publicado: (2017)

Copy number footprints of platinum-based anticancer therapies
por: Gonzalez, Santiago, et al.
Publicado: (2023)

CNValidator: validating somatic copy-number inference
por: Smith, Lucian P, et al.
Publicado: (2019)

Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma
por: Motzer, Robert J., et al.
Publicado: (2018)

Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival
por: Kamecki, Hubert, et al.
Publicado: (2023)

Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)
por: Powles, Thomas, et al.
Publicado: (2015)

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma
por: Nassar, Amin H., et al.
Publicado: (2019)

Common germline-somatic variant interactions in advanced urothelial cancer
por: Vosoughi, Aram, et al.
Publicado: (2020)

The emerging role of somatic tumor sequencing in the treatment of urothelial cancer
por: Wen, Lexiaochuan, et al.
Publicado: (2021)

Pan-cancer patterns of somatic copy-number alteration
por: Zack, Travis I., et al.
Publicado: (2013)

Robustness of the Autophagy Pathway to Somatic Copy Number Losses
por: Polo, Pierfrancesco, et al.
Publicado: (2022)

Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma
por: Lalani, Aly-Khan A., et al.
Publicado: (2018)

Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification
por: Van Bockstal, Mieke R., et al.
Publicado: (2020)

NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?
por: Gupta, Shilpa, et al.
Publicado: (2020)

Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma
por: Guan, Bao, et al.
Publicado: (2021)

Somatic mosaicism for copy-neutral loss of heterozygosity and DNA copy number variations in the human genome
por: Žilina, Olga, et al.
Publicado: (2015)

Somatic copy-number mosaicism in human skin revealed by induced pluripotent stem cells
por: Abyzov, Alexej, et al.
Publicado: (2012)

A Case Report Demonstrating the Potential Clinical Benefit of Exhaustive Molecular Profiling in an Aggressive Muscle-Invasive High-Grade Metastatic Urothelial Carcinoma
por: Ramírez de Olano, Amaya, et al.
Publicado: (2017)

The landscape of somatic copy-number alteration across human cancers
por: Beroukhim, Rameen, et al.
Publicado: (2010)

Controlled Somatic and Germline Copy Number Variation in the Mouse Model
por: Hérault, Yann, et al.
Publicado: (2010)

SCNVSim: somatic copy number variation and structure variation simulator
por: Qin, Maochun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rgh01ieffut188t1umgh3kfko4